Outlook Therapeutics (OTLK) Other Non Operating Income: 2017-2020
- Outlook Therapeutics' Other Non Operating Income rose 1554.92% to $6.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was -$3.6 million, marking a year-over-year change of. This contributed to the annual value of -$577,659 for FY2023, which is 43.67% up from last year.
- According to the latest figures from Q2 2020, Outlook Therapeutics' Other Non Operating Income is $6.2 million, which was up 176.47% from -$8.1 million recorded in Q4 2019.
- In the past 5 years, Outlook Therapeutics' Other Non Operating Income registered a high of $6.2 million during Q2 2020, and its lowest value of -$8.1 million during Q4 2019.
- Its 2-year average for Other Non Operating Income is -$773,327, with a median of -$423,686 in 2019.
- Data for Outlook Therapeutics' Other Non Operating Income shows a peak YoY skyrocketed of 1,554.92% (in 2020) over the last 5 years.
- Outlook Therapeutics' Other Non Operating Income (Quarterly) stood at -$1.3 million in 2017, then reached -$8.1 million in 2019, then soared by 1,554.92% to $6.2 million in 2020.
- Its Other Non Operating Income stands at $6.2 million for Q2 2020, versus -$8.1 million for Q4 2019 and -$423,686 for Q2 2019.
